News & Updates

Show Multimedia Only

In-store nutrition education enhances adherence to DASH diet

15 Apr 2022 by

Personalized nutrition advice conducted at grocery stores led to significant improvements in DASH* diet adherence, according to findings from the SuperWIN** trial.

In-store nutrition education enhances adherence to DASH diet

15 Apr 2022

GPs rank routine screening for AF as crucial as for cancers

15 Apr 2022 by

Screening for atrial fibrillation (AF) is considered to be as important as for common cancers and should be incorporated into other healthcare programmes such as flu vaccination and cancer screening programmes, based on data from the AFFECT-EU survey of GPs that was presented at EHRA 2022.

GPs rank routine screening for AF as crucial as for cancers

15 Apr 2022

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

15 Apr 2022

In the management of statin-treated patients with elevated cholesterol levels, the antisense oligonucleotide targeting angiopoietin-like protein 3 (ANGPTL3) vupanorsen reduces levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) and other lipid parameters, according to the results of TRANSLATE-TIMI 70.

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

15 Apr 2022

Which symptoms contribute to severe visual field damage in glaucoma?

15 Apr 2022

Variance in visual field (VD) damage is substantially driven by five patient-reported symptoms, according to a cross-sectional study.

Which symptoms contribute to severe visual field damage in glaucoma?

15 Apr 2022

T(11;14) translocation not linked to worse outcomes in multiple myeloma

15 Apr 2022

In patients with multiple myeloma (MM), the chromosome translocation t(11;14) does not seem to be associated with worse prognosis, resulting in similar treatment outcomes as other standard-risk subgroups, reports a recent study.

T(11;14) translocation not linked to worse outcomes in multiple myeloma

15 Apr 2022

Add-on ixazomib yields survival gains in post-transplant myeloma

15 Apr 2022

The combination of lenalidomide plus ixazomib in the maintenance treatment of patients with post-transplant myeloma leads to better progression-free survival (PFS) compared with lenalidomide alone in historical controls, according to a study.

Add-on ixazomib yields survival gains in post-transplant myeloma

15 Apr 2022

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

15 Apr 2022 by

Vupanorsen significantly reduces non–high-density lipoprotein cholesterol (non-HDL-C) levels in adults with hyperlipidaemia already taking statins, according to the TRANSLATE-TIMI 70* trial presented at ACC 2022.

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

15 Apr 2022

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

14 Apr 2022 by

Maintenance treatment with selinexor improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer who had previously received first-line chemotherapy, particularly those with endometrioid histology and wild-type p53, according to a study presented at SGO 2022.

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

14 Apr 2022

Aggressive BP control may ward off haemorrhagic stroke in patients with past ischaemic strokes

14 Apr 2022

Intensive blood pressure (BP) control helps reduce the risk of haemorrhagic stroke in patients with a history of ischaemic stroke, according to a post hoc analysis of the RESPECT* study.

Aggressive BP control may ward off haemorrhagic stroke in patients with past ischaemic strokes

14 Apr 2022

Tamsulosin–mirabegron combo improves urination frequency but not voiding volume

14 Apr 2022

Treatment with the combination of tamsulosin plus mirabegron following 125I-brachytherapy for prostate cancer falls short of improving voiding volume compared with tamsulosin monotherapy, although the combination helps with urination frequency and overactive bladder symptoms, according to a study.

Tamsulosin–mirabegron combo improves urination frequency but not voiding volume

14 Apr 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

In-store nutrition education enhances adherence to DASH diet

In-store nutrition education enhances adherence to DASH diet

GPs rank routine screening for AF as crucial as for cancers

GPs rank routine screening for AF as crucial as for cancers

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

Which symptoms contribute to severe visual field damage in glaucoma?

Which symptoms contribute to severe visual field damage in glaucoma?

T(11;14) translocation not linked to worse outcomes in multiple myeloma

T(11;14) translocation not linked to worse outcomes in multiple myeloma

Add-on ixazomib yields survival gains in post-transplant myeloma

Add-on ixazomib yields survival gains in post-transplant myeloma

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

Aggressive BP control may ward off haemorrhagic stroke in patients with past ischaemic strokes

Aggressive BP control may ward off haemorrhagic stroke in patients with past ischaemic strokes

Tamsulosin–mirabegron combo improves urination frequency but not voiding volume

Tamsulosin–mirabegron combo improves urination frequency but not voiding volume